On Wednesday, December 4, at 4:30 pm, Vanessa Hubbard-Lucey, PhD, MBA, director of CRI's Clinical Accelerator and Venture Fund, is giving a talk on "Challenges and opportunities in designing immuno-oncology trials: A non-profit perspective."
The World Vaccine & Immunotherapy Congress West Coast 2019 focuses on integrating the technologies revolutionizing immunotherapy and its impact on vaccine development with 500+ attendees, 200+ speakers, and four streams: immune profiling, cancer immunotherapy, vaccine development, and new technology. This congress is designed for top decision makers of the vaccine and immunotherapy industry with both scientific and commercial interests, specifically interested in both learning and partnering.
World Vaccine & Immunotherapy Congress West Coast 2019 is held December 2-25, 2019, at the San Francisco Airport Marriott Waterfront, San Francisco, CA.
Banner photo by Joshua Sortino on Unsplash
